Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
89.34
-0.90 (-1.00%)
Aug 1, 2025, 4:00 PM - Market closed
Paycor HCM Revenue
In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth. Medtronic had revenue of $8.93B in the quarter ending April 25, 2025, with 3.94% growth.
Revenue (ttm)
$33.54B
Revenue Growth
+3.62%
P/S Ratio
3.42
Revenue / Employee
$353,021
Employees
95,000
Market Cap
114.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
MDT News
- 17 hours ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 1 day ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 1 day ago - Medtronic: Growth Challenges Persist - Seeking Alpha
- 11 days ago - Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes - PRNewsWire
- 24 days ago - Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company - PRNewsWire
- 4 weeks ago - Medtronic: Margin Inflection With Diabetes Spin - Key Drivers - Seeking Alpha
- 4 weeks ago - Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap - Seeking Alpha
- 5 weeks ago - Medtronic Board appoints Dr. Joon Lee as a new director - PRNewsWire